Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?

With majority of ischemic strokes attributable to atherothrombosis and many being predictable after transient ischemic attacks (TIA), the role of early secondary prevention with antiplatelet agents is under renewed investigation. Prior major clinical trials of various secondary stroke prevention reg...

Description complète

Détails bibliographiques
Auteurs principaux: Clotilde Balucani, Kristian Barlinn, Zeljko Zivanovic, Lucilla Parnetti, Mauro Silvestrini, Andrei V. Alexandrov
Format: Article
Langue:English
Publié: Hindawi Limited 2010-01-01
Collection:Stroke Research and Treatment
Accès en ligne:http://dx.doi.org/10.4061/2010/427418